Guided Therapeutics (GTHP) Operating Margin Growth (1y) (2011 - 2025)
Guided Therapeutics (GTHP) Operating Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 146.00 |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.33 Mn |
| Dec 31, 2024 | -5.19 Mn |
| Mar 31, 2024 | -215,152.00 |
| Jun 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 502,818.00 |
| Sep 30, 2022 | -3.82 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Dec 31, 2021 | 42,700.00 |
| Sep 30, 2021 | -236,446.00 |
| Dec 31, 2020 | -12,075.00 |
| Sep 30, 2020 | 1.86 Mn |
| Dec 31, 2019 | 3,780.00 |
| Sep 30, 2019 | -710,000.00 |
| Jun 30, 2019 | -2.66 Mn |
| Mar 31, 2019 | 797,222.00 |
| Dec 31, 2018 | -38,587.00 |
| Sep 30, 2018 | -764,242.00 |
| Jun 30, 2018 | -552,486.00 |
| Mar 31, 2018 | -695,238.00 |
| Dec 31, 2017 | -91,240.00 |